High-density lipoprotein, mitochondrial dysfunction and cell survival mechanisms

Chemistry and Physics of Lipids

Volumn 199, Issue , 2016, Pages 161-169

  White, C Roger ^a   Giordano, Samantha ^a   Anantharamaiah, G M ^b,c  

^a University of Alabama at Birmingham and Birmingham Veterans Affairs Medical Center   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

ApoA I; Hdl; Ischemia reperfusion; Mitochondrion; Myocardium; Sphingosine 1 Phosphate

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; SPHINGOSINE 1 PHOSPHATE; STAT3 PROTEIN;

ARTICLE; AUTOPHAGY; BIOENERGY; CARDIAC MUSCLE CELL; CELL SURVIVAL; HEART FUNCTION; HEART MUSCLE INJURY; HEART PROTECTION; HUMAN; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; ANIMAL; ENERGY METABOLISM; METABOLISM; PATHOLOGY;

ANIMALS; AUTOPHAGY; CELL SURVIVAL; ENERGY METABOLISM; HUMANS; LIPOPROTEINS, HDL; MITOCHONDRIA; REPERFUSION INJURY;

EID: 84965105022     PISSN: 00093084     EISSN: 18732941     Source Type: Journal    
DOI: 10.1016/j.chemphyslip.2016.04.007     Document Type: Article

References (149)

1. Amo, T., Sato, S., Saiki, S., Wolf, A.M., Toyomizu, M., Gautier, C.A., Shen, J., Ohta, S., Hattori, N., Mitochondrial membrane potential decrease caused by loss of PINK1 is not due to proton leak, but to respiratory chain defects. Neurobiol. Dis. 41 (2011), 111–118.
2. Ansell, B.J., Watson, K.E., Fogelman, A.M., Navab, M., Fonarow, G.C., High-density lipoprotein function: recent advances. J. Am. Coll. Cardiol. 46 (2005), 1792–1798.
3. Ashby, D., Gamble, J., Vadas, M., Fidge, N., Siggins, S., Rye, K.A., Barter, P.J., Lack of an effect of serum amyloid A (SAA) on the ability of high-density lipoproteins to inhibit endothelial cell adhesion molecular expression. Atherosclerosis 154 (2001), 113–121.
4. Assmann, G., Gotto, A.M., HDL cholesterol and protective factors in atherosclerosis. Circulation, 2004, III–II8.
5. Assmann, G., Nofer, J.R., Atheroprotective effects of high-density lipoproteins. Annu. Rev. Med. 54 (2003), 321–341.
6. Baker, P.W., Rye, K.A., Gamble, J.R., Vadas, M.A., Barter, P.J., Ability of reconstituted high density lipoproteins to inhibit cytokine-induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells. J. Lipid Res. 40 (1999), 345–353.
7. Baotic, I., Ge, Z.D., Sedlic, F., Coon, A., Weihrauch, D., Warltier, D.C., Kersten, J.R., Apolipoprotein A-1 mimetic D-4F enhances isoflurane-induced eNOS signaling and cardioprotection during acute hyperglycemia. Am. J. Physiol. 305 (2013), H219–H227.
8. Bashtovyy, D., Jones, M.K., Anantharamaiah, G.M., Segrest, J.P., Sequence conservation of apolipoprotein A-I affords novel insights into HDL structure-function. J. Lipid Res. 52 (2011), 435–450.
9. Becker, L.B., New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc. Res. 61 (2004), 461–470.
10. Blaho, V.A., Hla, T., An update on the biology of sphingosine 1-phosphate receptors. J. Lipid Res. 55 (2014), 1596–1608.
11. Boden, W.E., High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the veterans affairs high-density lipoprotein intervention trial. Am. J. Cardiol. 86 (2000), 19L–22L.
12. Boengler, K., Hilfiker-Kleiner, D., Heusch, G., Schulz, R., Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion. Basic Res. Cardiol. 105 (2010), 771–785.
13. Bopassa, J.C., Michel, P., Gateau-Roesch, O., Ovize, M., Ferrera, R., Low-pressure reperfusion alters mitochondrial permeability transition. Am. J. Physiol. 288 (2005), H2750–2755.
14. Brinkmann, V., Cyster, J.G., Hla, T., FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function. Am. J. Transplant. 4 (2004), 1019–1025.
15. Brulhart-Meynet, M.C., Braunersreuther, V., Brinck, J., Montecucco, F., Prost, J.-C., Thomas, A., Galan, K., Pelli, G., Pedretti, S., Vuilleumier, N., Mach, F., Lecour, S., James, R.W., Frias, M.A., Improving reconstituted HDL composition for efficient post-ischemic reduction of ischemia reperfusion injury. PLoS One, 10(3), 2015, e0119664, 10.1371/journal.pone.0119664.
16. Casillas-Ramirez, A., Mosbah, I.B., Ramalho, F., Rosello-Catafau, J., Peralta, C., Past and future approaches to ischemia-reperfusion lesion associated with liver transplantation. Life Sci. 79 (2006), 1881–1894.
17. Chen, Q., Hoppel, C.L., Lesnefsky, E.J., Blockade of electron transport before cardiac ischemia with the reversible inhibitor amobarbital protects rat heart mitochondria. J. Pharmacol. Exp. Ther. 316 (2006), 200–207.
18. Chen, Q., Camara, A.K., Stowe, D.F., Hoppel, C.L., Lesnefsky, E.J., Modulation of electron transport protects cardiac mitochondria and decreases myocardial injury during ischemia and reperfusion. Am. J. Physiol. 292 (2007), C137–147.
19. Chen, Q., Yin, G., Stewart, S., Hu, Y., Lesnefsky, E.J., Isolating the segment of the mitochondrial electron transport chain responsible for mitochondrial damage during cardiac ischemia. Biochem. Biophys. Res. Commun. 397 (2010), 656–660.
20. Chopra, M., Golden, H.B., Mullapudi, S., Dowhan, W., Dostal, D.E., Sharma, A.C., Modulation of myocardial mitochondrial mechanisms during severe polymicrobial sepsis in the rat. PLoS One, 6(6), 2011, e21285, 10.1371/journal.pone.0021285.
21. Christoffersen, C., Nielsen, L.B., Axler, O., Andersson, A., Johnsen, A.H., Dahlbäck, B., Isolation and characterization of human apolipoprotein M-containing lipoproteins. J. Lipid Res. 47 (2006), 1833–1843.
22. Christoffersen, C., Jauhiainen, M., Moser, M., Porse, B., Ehnholm, C., Boesl, M., Dahlback, B., Nielsen, L.B., Effect of apolipoproteinM on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice. J. Biol. Chem. 283 (2008), 1839–1847.
23. Christoffersen, C., Obinata, H., Kumaraswamy, S.B., Galvani, S., Ahnström, J., Sevvana, M., Egerer-Sieber, C., Muller, Y.A., Hla, T., Nielsen, L.B., Dahlbäck, B., Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 9613–9618.
24. Cockerill, G.W., McDonald, M.C., Mota-Filipe, H., Cuzzocrea, S., Miller, N.E., Thiemermann, C., High density lipoproteins reduce organ injury and organ dysfunction in a rat model of hemorrhagic shock. FASEB J. 15 (2001), 1941–1952.
25. Dadabayev, A.R., Yin, G., Latchoumycandane, C., McIntyre, T.M., Lesnefsky, E.J., Penn, M.S., Apolipoprotein A1 regulates coenzyme Q10 absorption, mitochondrial function, and infarct size in a mouse model of myocardial infarction. J. Nutr. 144 (2014), 1030–1036.
26. Dahlbäck, B., Nielsen, L.B., Apolipoprotein M affecting lipid metabolism or just catching a ride with lipoproteins in the circulation?. Cell. Mol. Life Sci. 66 (2009), 559–564.
27. Datta, G., Chaddha, M., Hama, S., Navab, M., Fogelman, A.M., Garber, D.W., Mishra, V.K., Epand, R.M., Epand, R.F., Lund-Katz, S., Phillips, M.C., Segrest, J.P., Anantharamaiah, G.M., Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide. J. Lipid Res. 42 (2001), 1096–1104.
28. Decker, R.S., Wildenthal, K., Lysosomal alterations in hypoxic and reoxygenated hearts. I. Ultrastructural and cytochemical changes. Am. J. Pathol. 98 (1980), 425–444.
29. Deshpande, G.P., McCarthy, J., Mardikar, H., Lecour, S., Opie, L., Effects of sphingosine-1-phosphate on acute contractile heart failure (ACHF). Cardiovasc. Drugs Ther. 24 (2010), 459–460.
30. Deuchar, G.A., Opie, L.H., Lecour, S., TNFalpha is required to confer protection in an in vivo model of classical ischaemic preconditioning. Life Sci. 80 (2007), 1686–1691.
31. Ditiatkovski, M., D'Souza, W., Kesani, R., Chin-Dusting, J., de Haan, J.B., Remaley, A., Sviridov, D., An apolipoprotein A-I mimetic peptide designed with a reductionist approach stimulates reverse cholesterol transport and reduces atherosclerosis in mice. PLoS One, 8, 2013, e68802, 10.1371/journal.pone.0068802.
32. Duan, J., Dahlbäck, B., Villoutreix, B.O., Proposed lipocalin fold for apolipoprotein M based on bioinformatics and site-directed mutagenesis. FEBS Lett. 499 (2001), 127–132.
33. Dunbar, R.L., Rader, D.J., Current drug options for raising HDL cholesterol. Curr. Treat. Options Cardiovasc. Med. 7 (2005), 15–23.
34. Dutta, D., Calvani, R., Bernabei, R., Leeuwenburgh, C., Marzetti, E., Contribution of impaired mitochondrial autophagy to cardiac aging mechanisms and therapeutic opportunities. Circ. Res. 110 (2012), 1125–1138.
35. Elsøe, S., Christoffersen, C., Luchoomun, J., Turner, S., Nielsen, L.B., Apolipoprotein M promotes mobilization of cellular cholesterol in vivo. Biochim. Biophys. Acta 1831 (2013), 1287–1292.
36. Fazio, S., Linton, M.F., Sorting out the complexities of reverse cholesterol transport: CETP polymorphisms, HDL, and coronary disease. J. Clin. Endocrinol. Metab. 91 (2006), 3273–3275.
37. Fink, M.P., Cytopathic hypoxia. Mitochondrial dysfunction as mechanism contributing to organ dysfunction in sepsis. Crit. Care Clin. 17 (2001), 219–237.
38. Forner, F., Foster, L.J., Campanaro, S., Valle, G., Mann, M., Quantitative proteomic comparison of rat mitochondria from muscle, heart, and liver. Mol. Cell. Proteom. 5 (2006), 608–619.
39. Frias, M.A., James, R.W., Gerber-Wicht, C., Lang, U., Native and reconstituted HDL activate STAT3 in ventricular cardiomyocytes via ERK1/2: role of sphingosine-1-phosphate. Cardiovasc. Res. 82 (2009), 313–323.
40. Frias, M.A., Lecour, S., James, R.W., Pedretti, S., High density lipoprotein/sphingosine-1-phosphate-induced cardioprotection: role of STAT3 as part of the SAFE pathway. JAK-STAT 1 (2012), 92–100.
41. Frias, M.A., Pedretti, S., Hacking, D., Somers, S., Lacerda, L., Opie, L.H., James, R.W., Lecour, S., HDL protects against ischemia reperfusion injury by preserving mitochondrial integrity. Atherosclerosis 228 (2013), 110–116.
42. Frink, M., Kaudel, C.P., Hildebrand, F., Pape, H.C., Klempnauer, J., Winkler, M., Krettek, C., van Griensven, M., FTY720 improves survival after transient ischemia and reperfusion of the hind limbs. J. Trauma 63 (2007), 263–267.
43. Garber, D.W., Datta, G., Chaddha, M., Palgunachari, M.N., Hama, S., Navab, M., Fogelman, A.M., Segrest, J.P., Anantharamaiah, G.M., A new synthetic class A amphipathic peptide analogue protects mice from diet-induced atherosclerosis. J. Lipid Res. 42 (2001), 545–552.
44. Gerster, R., Eloranta, J.J., Hausmann, M., Ruiz, P.A., Cosin-Roger, J., Terhalle, A., Ziegler, U., Kullak-Ublick, G.A., von Eckardstein, A., Rogler, G., Anti-inflammatory function of high-density lipoproteins via autophagy of IkB kinase. Cell. Mol. Gastroenterol. Hepatol. 1 (2015), 171–187.
45. Getz, G.S., Reardon, C.A., The structure/function of apoprotein A-I mimetic peptides: an update. Curr. Opin. Endocrinol. Diabetes Obes. 21 (2014), 129–133.
46. Ghazzal, Z.B., Dhawan, S.S., Sheikh, A., Douglas, J.S., Veledar, E., Mavromatis, K., Pohlel, F.K., Vaccarino, V., Usefulness of serum high-density lipoprotein cholesterol level as an independent predictor of one-year mortality after percutaneous coronary interventions. Am. J. Cardiol. 103 (2009), 902–906.
47. Gomaraschi, M., Calabresi, L., Rossoni, G., Iametti, S., Franceschini, G., Stonik, J.A., Remaley, A.T., Anti-inflammatory and cardioprotective activities of synthetic high-density lipoprotein containing apolipoprotein A-I mimetic peptides. J. Pharmacol. Exp. Ther. 324 (2008), 776–783.
48. Gottlieb, R.A., Gustafsson, A.B., Mitochondrial turnover in the heart. Biochim. Biophys. Acta 1813 (2011), 1295–1301.
49. Gu, X., Huang, Y., Levison, B.S., Gerstenecker, G., DiDonato, A.J., Hazen, L.B., Lee, J., Gogonea, V., DiDonato, J.A., Hazen, S.L., Identification of critical paraoxonase 1 residues involved in high density lipoprotein interaction. J. Biol. Chem. 291 (2016), 1890–1904.
50. Gustafsson, A.B., Gottlieb, R.A., Autophagy in ischemic heart disease. Circ. Res. 104 (2009), 150–158.
51. Hausenloy, D.J., Yellon, D.M., New directions for protecting the heart against ischaemia-reperfusion injury: targeting the reperfusion injury salvage kinase (RISK)-pathway. Cardiovasc. Res. 61 (2004), 448–460.
52. Hausenloy, D.J., Yellon, D.M., Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection. Heart Fail. Rev. 12 (2007), 217–234.
53. Hausenloy, D.J., Maddock, H.L., Baxter, G.F., Yellon, D.M., Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?. Cardiovasc. Res. 55 (2002), 534–543.
54. Hausenloy, D.J., Tsang, A., Yellon, D.M., The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. Trends Cardiovasc. Med. 15 (2005), 69–75.
55. Heusch, G., Boengler, K., Schulz, R., Inhibition of mitochondrial permeability transition pore opening: the holy grail of cardioprotection. Basic Res. Cardiol. 105 (2010), 151–154.
56. Heusch, G., Musiolik, J., Gedik, N., Skyschally, A., Mitochondrial STAT3 activation and cardioprotection by ischemic postconditioning in pigs with regional myocardial ischemia/reperfusion. Circ. Res. 109 (2011), 1302–1308.
57. Hill, B.G., Benavides, G.A., Lancaster, J.R., Ballinger, S., Dell'Italia, L., Zhang, J., Darley-Usmar, V.M., Integration of cellular bioenergetics with mitochondrial quality control and autophagy. Biol. Chem. 393 (2012), 1485–1512.
58. Huang, C., Yitzhaki, S., Perry, C.N., Liu, W., Giricz, Z., Mentzer, R.M., Gottlieb, R.A., Autophagy induced by ischemic preconditioning is essential for cardioprotection. J. Cardiovasc. Trans. Res. 3 (2010), 365–373.
59. Huang, Y., Wu, Z., Riwanto, M., Gao, S., Levison, B.S., Gu, X., Fu, X., Wagner, M.A., Besler, C., Gerstenecker, G., Zhang, R., Li, X.M., DiDonato, A.J., Gogonea, V., Tang, W.H.W., Smith, J.D., Plow, E.F., Fox, P.L., Shih, D.M., Lusis, A.J., Fisher, E.A., DiDonato, J.A., Landmesser, U., Hazen, S.L., Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex. J. Clin. Invest. 123 (2013), 3815–3828.
60. Jaeschke, H., Mitchell, J.R., Mitochondria and xanthine oxidase both generate reactive oxygen species in isolated perfused rat liver after hypoxic injury. Biochem. Biophys. Res. Commun. 160 (1989), 140–147.
61. James, R.W., Frias, M.A., Lecour, S., Lipid-induced modulation of protective signalling pathways in cardiovascular disease: the role of high density lipoproteins. Curr. Signal Transduct.Therapy 7 (2012), 96–103.
62. Jin, Z.Q., Zhou, H.Z., Zhu, P., Honbo, N., Mochly-Rosen, D., Messing, R.O., Goetzl, E.J., Karliner, J.S., Gray, M.O., Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKC epsilon knockout mouse hearts. Am. J. Physiol. 282 (2002), H1970–1977.
63. Juhaszova, M., Zorov, D.B., Yaniv, Y., Nuss, H.B., Wang, S., Sollott, S.J., Role of glycogen synthase kinase-3in cardioprotection. Circ. Res. 104 (2009), 1240–1252.
64. Kalakech, H., Hibert, P., Prunier-Mirebeau, D., Tamareille, S., Letournel, F., Macchi, L., Pinet, F., Furber, A., Prunier, F., RISK and SAFE signaling pathway involvement in apolipoprotein A-I-induced cardioprotection. PLoS One, 9(9), 2014, e107950, 10.1371/journal.pone.0107950.
65. Kalogeris, T., Baines, C.P., Krenz, M., Korthuis, R.J., Cell biology of ischemia/reperfusion injury. Int. Rev. Cell Mol. Biol. 298 (2012), 229–317.
66. Kanamori, H., Takemura, G., Goto, K., Maruyama, R., Tsujimoto, A., Ogino, A., Takeyama, T., Kawaguchi, T., Watanabe, T., Fujiwara, T., Fujiwara, H., Seishima, M., Minatoguchi, S., The role of autophagy emerging in postinfarction cardiac remodelling. Cardiovasc. Res. 91 (2011), 330–339.
67. Karliner, J.S., Sphingosine kinase and sphingosine 1-phosphate in cardioprotection. J. Cardiovasc. Pharmacol. 53 (2009), 189–197.
68. Kaudel, C.P., Frink, M., van Griensven, M., Schmiddem, U., Probst, C., Bergmann, S., Krettek, C., Klempnauer, J., Winkler, M., FTY720 application following isolated warm liver ischemia improves long-term survival and organ protection in a mouse model. Transplant. Proc. 39 (2007), 493–498.
69. Keul, G., Schmidt, C., Herrmann, J., Keul, P., Schäfers, M., Herrgott, I., Mersmann, J., Larmann, J., Hermann, S., Stypmann, J., Schober, O., Hildebrand, R., Schulz, R., Heusch, G., Haude, M., von Wnuck Lipinski, K., Herzog, C., Schmitz, M., Erbel, R., Chun, J., Levkau, B., High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart again ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor. Circulation 114 (2006), 1403–1409.
70. Keul, P., Sattler, K., Levkau, B., HDL and its sphingosine-1-phosphate content in cardioprotection. Heart Fail. Rev. 12 (2007), 301–306.
71. Kim, I., Rodríguez-Enríquez, S., Lemasters, J.J., Selective degradation of mitochondria by mitophagy. Arch. Biochem. Biophys. 462 (2007), 245–253.
72. Kim, J.S., Nitta, T., Mohuczy, D., O'Malley, K.A., Moldawer, L.L., Dunn, W.A., Behrns, K.E., Impaired autophagy: a mechanism of mitochondrial dysfunction in anoxic rat hepatocytes. Hepatology 47 (2008), 1725–1736.
73. Kimura, T., Sato, K., Kuwabara, A., Tomura, H., Ishiwara, M., Kobayashi, I., Ui, M., Okajima, F., Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells. J. Biol. Chem. 276 (2001), 31780–31785.
74. Kimura, T., Sato, K., Malchinkhuu, E., Tomura, H., Tamama, K., Kuwabara, A., Murakami, M., Okajima, F., High-density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors. Arterioscler. Thromb. Vasc. Biol. 23 (2003), 1283–1288.
75. Kirkegaard, K., Taylor, M.P., Jackson, W.T., Cellular autophagy: surrender, avoidance and subversion by microorganisms. Nat. Rev. Microbiol. 2 (2004), 301–314.
76. Kleinbongard, P., Schulz, R., Heusch, G., TNFα in myocardial ischemia/reperfusion, remodeling and heart failure. Heart Fail. Rev. 16 (2011), 49–69.
77. Kontush, A., Therond, P., Zerrad, A., Couturier, M., Négre-Salvayre, A., de Souza, J.A., Chantepie, S., Chapman, M.J., Preferential sphingosine-1-phosphate enrichment and sphingomyelin depletion are key features of small dense HDL3 particles: relevance to antiapoptotic and antioxidative activities. Arterioscler. Thromb. Vasc. Biol. 27 (2007), 1843–1849.
78. Lacerda, L., Somers, S., Opie, L.H., Lecour, S., Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway. Cardiovasc. Res. 84 (2009), 201–208.
79. Lavieu, G., Scarlatti, F., Sala, G., Carpentier, S., Levade, T., Ghidoni, R., Botti, J., Codogno, P., Regulation of autophagy by sphingosine kinase 1 and its role in cell survival during nutrient starvation. J. Biol. Chem. 281 (2006), 8518–8527.
80. Lecour, S., Suleman, N., Deuchar, G.A., Somers, S., Lacerda, L., Huisamen, B., Opie, L.H., Pharmacological preconditioning with tumor necrosis factor-alpha activates signal transducer and activator of transcription-3 at reperfusion without involving classic prosurvival kinases (Akt and extracellular signal-regulated kinase). Circulation 112 (2005), 3911–3918.
81. Lecour, S., Activation of the protective survivor activating factor enhancement (SAFE) pathway against reperfusion injury: does it go beyond the RISK pathway?. J. Mol. Cell. Cardiol. 47 (2009), 32–40.
82. Lemasters, J.J., Holmuhamedov, E., Voltage-dependent anion channel (VDAC) as mitochondrial governator-thinking outside the box. Biochim. Biophys. Acta 1762 (2006), 181–190.
83. Lemasters, J.J., Theruvath, T.P., Zhong, Z., Nieminen, A.L., Mitochondrial calcium and the permeability transition in cell death. Biochim. Biophys. Acta 1787 (2009), 1395–1401.
84. Lesnefsky, E.J., Chen, Q., Slabe, T.J., Stoll, M.S., Minkler, P.E., Hassan, M.O., Tandler, B., Hoppel, C.L., Ischemia, rather than reperfusion, inhibits respiration through cytochrome oxidase in the isolated, perfused rabbit heart: role of cardiolipin. Am. J. Physiol. 287 (2004), H258–267.
85. Lewis, G.F., Rader, D.J., New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ. Res. 96 (2005), 1221–1232.
86. Li, J., Xuan, W., Yan, R., Tropak, M.B., Jean-St-Michel, E., Liang, W., Gladstone, R., Backx, P.H., Kharbanda, R.K., Redington, A.N., Remote preconditioning provides potent cardioprotection via PI3K/Akt activation and is associated with nuclear accumulation of β-catenin. Clin. Sci. (Lond.) 120 (2011), 451–462.
87. Li, Y., Li, S., Qin, X., Hou, W., Dong, H., Yao, L., Xiong, L., The pleiotropic roles of sphingolipid signaling in autophagy. Cell Death Dis., 5, 2014, e1245, 10.1038/cddis.2014.215.
88. Ludovic Gomez, L., Paillard, M., Price, M., Chen, Q., Teixeira, G., Spiegel, S., Lesnefsky, E.J., A novel role for mitochondrial sphingosine-1-phosphate produced by sphingosine kinase-2 in PTP-mediated cell survival during cardioprotection. Basic Res. Cardiol. 106 (2011), 1341–1353.
89. Marchesi, M., Booth, E.A., Davis, T., Bisgaier, C.L., Lucchesi, B.R., Apolipoprotein A-IMilano and 1-palmitoyl-2-oleoyl phosphatidylcholine complex (ETC-216) protects the in vivo rabbit heart from regional ischemia-reperfusion injury. J. Pharmacol. Exp. Ther. 311 (2004), 1023–1031.
90. Marchesi, M., Booth, E.A., Rossoni, G., García, R.A., Hill, K.R., Sirtori, C.R., Bisgaier, C.L., Lucchesi, B.R., Apolipoprotein A-IMilano/POPC complex attenuates post-ischemic ventricular dysfunction in the isolated rabbit heart. Atherosclerosis 197 (2008), 572–578.
91. Merkwirth, C., Langer, T., Prohibitin function within mitochondria: essential roles for cell proliferation and cristae morphogenesis. Biochim. Biophys. Acta 1793 (2009), 27–32.
92. Miura, T., Tanno, M., Mitochondria and GSK-3beta in cardioprotection against ischemia/reperfusion injury. Cardiovasc. Drugs Ther. 24 (2010), 255–263.
93. Morel, S., Christoffersen, C., Rochemont, V., Montecucco, F., Frias, M., Pelli, G., Mach, F., James, R.W., Nielsen, L.B., Kwak, B.R., Molecular insight in apoM-S1P-induced cardioprotection against ischemia/reperfusion injury. Cardiovasc. Res., 103, 2014, S120.
94. Morel, S., Christoffersen, C., Axelsen, L.N., Montecucco, F., Rochemont, V., Frias, M.A., Mach, F., James, R.W., Naus, C.C., Chanson, M., Lampe, P.D., Nielsen, M.S., Nielsen, L.B., Kwak, B.R., Sphingosine-1-phosphate reduces ischaemia-reperfusion injury by phosphorylating the gap junction protein Connexin43. Cardiovasc. Res. 109 (2016), 385–396.
95. Navab, M., Anantharamaiah, G.M., Hama, S., Garber, D.W., Chaddha, M., Hough, G., Lallone, R., Fogelman, A.M., Oral administration of an Apo A-I mimetic peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol. Circulation 105 (2002), 290–292.
96. Navab, M., Anantharamaiah, G.M., Reddy, S.T., Van Lenten, B.J., Hough, G., Wagner, A., Nakamura, K., Garber, D.W., Datta, G., Segrest, J.P., Human apolipoprotein A-I mimetic peptides for the treatment of atherosclerosis. Curr. Opin. Investig. Drugs 4 (2003), 1100–1104.
97. Navab, M., Anantharamaiah, G.M., Reddy, S.T., Van Lenten, B.J., Hough, G., Wagner, A., Nakamura, K., Garber, D.W., Datta, G., Segrest, J.P., et al. Human apolipoprotein A-I mimetic peptides for the treatment of atherosclerosis. Curr. Opin. Investig. Drugs 4 (2003), 1100–1104.
98. Navab, M., Anantharamaiah, G.M., Fogelman, A.M., The role of high-density lipoprotein in inflammation. Trends Cardiovasc. Med. 15 (2005), 158–161.
99. Negoro, S., Kunisada, K., Tone, E., Funamoto, M., Oh, H., Kishimoto, T., Yamauchi-Takihara, K., Activation of JAK/STAT pathway transduces cytoprotective signal in rat acute myocardial infarction. Cardiovasc. Res. 47 (2000), 797–805.
100. Nissen, S.E., Tsunoda, T., Tuzcu, E.M., Schoenhagen, P., Cooper, C.J., Yasin, M., Eaton, G.M., Lauer, M.A., Sheldon, W.S., Grines, C.L., Halpern, S., Crowe, T., Blankenship, J.C., Kerensky, R., Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 290 (2003), 2292–2300.
101. Olsson, Anders G., Schwartz, Gregory G., Szarek, Michael, Sasiela, William J., Ezekowitz, Michael D., Ganz, Peter, Oliver, Michael F., Waters, David, Zeiher, Andreas, High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial. Eur. Heart J. 26 (2005), 890–896.
102. Pedretti, S., Raddatz, E., STAT3a interacts with nuclear GSK3beta and cytoplasmic RISK pathway and stabilizes rhythm in the anoxic-reoxygenated embryonic heart. Basic Res. Cardiol. 106 (2011), 355–369.
103. Pell, V.R., Chouchani, E.T., Murphy, M.P., Brookes, P., Krieg, T., Moving forwards by blocking back-flow: the yin and yang of MI therapy. Circ. Res. 118 (2016), 898–906.
104. Perrelli, M.G., Pagliaro, P., Penna, C.1, Ischemia/reperfusion injury and cardioprotective mechanisms: role of mitochondria and reactive oxygen species. World J.Cardiol. 3 (2011), 186–200.
105. Roberts, E., Guerrero, M., Urbano, M., Rosen, H., Sphingosine 1-phosphate receptor agonists: a patent review (2010–2012). Expert Opin. Ther. Pat. 23 (2013), 817–841.
106. Rodriguez-Enriquez, S., He, L., Lemasters, J.J., Role of mitochondrial permeability transition pores in mitochondrial autophagy. Int. J. Biochem. Cell Biol. 36 (2004), 2463–2472.
107. Rossoni, G., Gomaraschi, M., Berti, F., Sirtori, C.R., Franceschini, G., Calabresi, L., Synthetic high-density lipoproteins exert cardioprotective effects in myocardial ischemia/reperfusion injury. J. Pharmacol. Exp. Ther. 308 (2004), 79–84.
108. Sangle, G.V., Chowdhury, S.K.R., Xie, X., Stelmack, G.L., Halayko, A.J., Shen, G.X., Impairment of mitochondrial respiratory chain activity in aortic endothelial cells induced by glycated low-density lipoprotein. Free Radic. Biol. Med. 48 (2010), 781–790.
109. Sattler, K., Levkau, B., Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection. Cardiovasc. Res. 82 (2009), 201–211.
110. Sattler, K.J., Elbasan, S., Keul, P., Elter-Schulz, M., Bode, C., Gräler, M.H., Bröcker-Preuss, M., Budde, T., Erbel, R., Heusch, G., Levkau, B., Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease. Basic Res. Cardiol. 105 (2010), 821–832.
111. Sattler, K., Gräler, M., Keul, P., Weske, S., Reimann, C.M., Jindrová, H., Kleinbongard, P., Sabbadini, R., Bröcker-Preuss, M., Erbel, R., Heusch, G., Levkau, B., Defects of high-density lipoproteins in Coronary artery disease caused by low sphingosine-1-phosphate content: correction by sphingosine-1-phosphate-loading. J. Am. Coll. Cardiol. 66 (2015), 1470–1485.
112. Sazanov, L.A., A giant molecular proton pump: structure and mechanism of respiratory complex I. Nat. Rev. Mol. Cell Biol. 16 (2015), 375–388.
113. Schultz, J.R., Verstuyft, J.G., Gong, E.L., Nichols, A.V., Rubin, E.M., Protein composition determines the anti-atherogenic properties of HDL in transgenic mice. Nature 365 (1993), 762–764.
114. Shah, P.K., Kaul, S., Nilsson, J., Cercek, B., Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an idea whose time for testing is coming, part I. Circulation 104 (2001), 2376–2383.
115. Shah, A.S., Tan, L., Long, J.L., Davidson, W.S., Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond. J. Lipid Res. 54 (2013), 2575–2585.
116. Shao, B., Tang, C., Heinecke, J.W., Oram, J.F., Oxidation of apolipoprotein A-I by myeloperoxidase impairs the initial interactions with ABCA1 required for signaling and cholesterol export. J. Lipid Res. 51 (2010), 1849–1858.
117. Shen, G.X., Mitochondrial dysfunction, oxidative stress and diabetic cardiovascular disorders. Cardiovasc. Hematol. Disord. Drug Targets 12 (2012), 106–112.
118. Singer, M., Brealey, D., Mitochondrial dysfunction in sepsis. Biochem. Soc. Symp. 66 (1999), 149–166.
119. Somers, S.J., Frias, M., Lacerda, L., Opie, L.H., Lecour, S., Interplay between SAFE and RISK pathways in sphingosine-1-phosphate–induced cardioprotection. Cardiovasc. Drugs Ther. 26 (2012), 227–237.
120. Stadler, J., Bentz, B.G., Harbrecht, B.G., Di Silvio, M., Curran, R.D., Billiar, T.R., Hoffman, R.A., Simmons, R.L., Tumor necrosis factor alpha inhibits hepatocyte mitochondral respiration. Ann. Surg. 216 (1992), 539–546.
121. Strub, G.M., Paillard, M., Liang, J., Gomez, L., Allegood, J.C., Hait, N.C., Maceyka, M., Price, M.M., Chen, Q., Simpson, D.C., Kordula, T., Milstien, S., Lesnefsky, E.J., Spiegel, S., Sphingosine-1-phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration. FASEB J. 25 (2011), 600–612.
122. Sun, K., Xie, X., Liu, Y., Han, Z., Zhao, X., Cai, N., Zhang, S., Song, J., Wei, L., Autophagy lessens ischemic liver injury by reducing oxidative damage. Cell Biosci., 3, 2013, 26 http://www.cellandbioscience.com/content/3/1/26.
123. Szczepanek, K., Chen, Q., Derecka, M., Salloum, F.N., Zhang, Q., Szelag, M., Cichy, J., Kukreja, R.C., Dulak, J., Lesnefsky, E.J., Larner, A.C., Mitochondrial-targeted signal transducer and activator of transcription 3 (STAT3) protects against ischemia-induced changes in the electron transport chain and the generation of reactive oxygen species. J. Biol. Chem. 286 (2011), 29610–29620.
124. Tammineni, P., Anugula, C., Mohammed, F., Anjaneyulu, M., Larner, A.C., Sepuri, N.B., The import of the transcription factor STAT3 into mitochondria depends on GRIM-19, a component of the electron transport chain. J. Biol. Chem. 288 (2013), 4723–4732.
125. Tang, C., Vaughan, A.M., Anantharamaiah, G.M., Oram, J.F., Janus kinase 2 modulates the lipid-removing but not protein-stabilizing interactions of amphipathic helices with ABCA1. J. Lipid Res. 47 (2006), 107–114.
126. Tang, C., Liu, Y., Kessler, P.S., Vaughan, A.M., Oram, J.F., The macrophage cholesterol exporter ABCA1 functions as an anti-inflammatory receptor. J. Biol. Chem. 284 (2009), 32336–32343.
127. Tao, R., Hoover, H.E., Honbo, N., Kalinowski, M., Alano, C.C., Karliner, J.S., Raffai, R., High-density lipoprotein determines adult mouse cardiomyocyte fate after hypoxia-reoxygenation through lipoprotein-associated sphingosine 1-phosphate. Am. J. Physiol. 298 (2010), H1022–1028.
128. Theilmeier, G., Schmidt, C., Herrmann, J., Keul, P., Schäfers, M., Herrgott, I., Mersmann, J., Larmann, J., Hermann, S., Stypmann, J., Schober, O., Hildebrand, R., Schulz, R., Heusch, G., Haude, M., von Wnuck, L.K., Herzog, C., Schmitz, M., Erbel, R., Chun, J., Levkau, B., High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart again ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor. Circulation 114 (2006), 1403–1409.
129. Tolle, M., Levkau, B., Keul, P., Brinkmann, V., Giebing, G., Schonfelder, G., Schafers, M., von Wnuck Lipinski, K., Jankowski, J., Jankowski, V., Chun, J., Zidek, W., Van der Giet, M., Immunomodulator FTY720 induces eNOS-dependent arterial vasodilatation via the lysophospholipid receptor S1P3. Circ. Res. 96 (2005), 913–920.
130. van Leeuwen, H.J., Heezius, E.C., Dallinga, G.M., van Strijp, J.A., Verhoef, J., van Kessel, K.P., Lipoprotein metabolism in patients with severe sepsis. Crit. Care Med. 31 (2003), 1359–1366.
131. Vakili, L., Hama, S., Kim, J.B., Tien, D., Safarpoor, S., Ly, N., Vakili, G., Hough, G., Navab, M., The effect of HDL mimetic peptide 4F on PON1. Adv. Exp. Med. Biol. 660 (2009), 167–172.
132. Vecoli, C., Cao, J., NegliaD. Inoue, K., Sodhi, K., Vanella, L., Gabrielson, K.K., Bedja, D., Paolocci, N., L'Abbate, A., Abraham, N.G., Apolipoprotein A-I mimetic peptide L-4F prevents myocardial and coronary dysfunction in diabetic mice. J. Cell. Biochem. 112 (2011), 2616–2626.
133. Venkataraman, K., Lee, Y.M., Michaud, J., Thangada, S., Ai, Y., Bonkovsky, H.L., Parikh, N.S., Habrukowich, C., Hla, T., Vascular endothelium as a contributor of plasma sphingosine 1-phosphate. Circ. Res. 102 (2008), 669–676.
134. Verma, S., Fedak, P.W.M., Weisel, R.D., Butany, J., Rao, V., Maitland, A., Li, R.K., Dhillon, B., Yau, T.M., Fundamentals of reperfusion injury for the clinical cardiologist. Circulation 105 (2002), 2332–2336.
135. Vinten-Johansen, J., Yellon, D.M., Opie, L.H., Postconditioning: a simple, clinically applicable procedure to improve revascularization in acute myocardial infarction. Circulation 112 (2005), 2085–2088.
136. Vinten-Johansen, J., Zhao, Z.Q., Jiang, R., Zatta, A.J., Dobson, G.P., Preconditioning and postconditioning: innate cardioprotection from ischemia-reperfusion injury. J. Appl. Physiol. 103 (2007), 1441–1448.
137. Wang, C., Chen, K., Xia, Y., Dai, W., Wang, F., Shen, M., Cheng, P., Wang, J., Lu, J., Zhang, Y., Yang, J., Zhu, R., Zhang, H., Li, J., Zheng, Y., Zhou, Y., Guo, C., N-Acetylcysteine attenuates ischemia-reperfusion-induced apoptosis and autophagy in mouse liver via regulation of the ROS/JNK/Bcl-2 pathway. PLoS One, 9(9), 2014, e108855, 10.1371/journal.pone.0108855.
138. Wegrzyn, J., Potla, R., Chwae, Y.J., Sepuri, N.B., Zhang, Q., Koeck, T., Derecka, M., Szczepanek, K., Szelag, M., Gornicka, A., Moh, A., Moghaddas, S., Chen, Q., Bobbili, S., Cichy, J., Dulak, J., Baker, D.P., Wolfman, A., Stuehr, D., Hassan, M.O., Fu, X.Y., Avadhani, N., Drake, J.I., Fawcett, P., Lesnefsky, E.J., Larner, A.C., Function of mitochondrial Stat3 in cellular respiration. Science 323 (2009), 793–797.
139. Weisner, P., Leidl, K., Boettcher, A., Schmitz, G., Liebisch, G., Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry. J. Lipid Res. 50 (2009), 574–585.
140. Wolfrum, C., Poy, M.N., Stoffel, M., Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis. Nat. Med. 11 (2005), 418–422.
141. Wong, R., Steenbergen, C., Murphy, E., Mitochondrial permeability transition pore and calcium handling. Methods Mol. Biol. 810 (2012), 235–242.
142. Wu, A., Hinds, C.J., Thiemermann, C., High-density lipoproteins in sepsis and septic shock: metabolism, actions, and therapeutic applications. Shock 21 (2004), 210–221.
143. Wu, B.J., Ong, K.L., Shrestha, S., Chen, K., Tabet, F., Barter, P.J., Rye, K.A., Inhibition of arthritis in the Lewis rat by apolipoprotein A-I and reconstituted high-density lipoproteins. Arterioscler. Thromb. Vasc. Biol. 34 (2014), 543–551.
144. Yan, W.J., Dong, H.L., Xiong, L.Z., The protective roles of autophagy in ischemic preconditioning. Acta Pharmacol. Sin. 34 (2013), 636–643.
145. Yatomi, Y., Ozaki, Y., Ohmori, T., Igarashi, Y., Sphingosine 1-phosphate: synthesis and release. Prostaglandins Other Lipid Mediat. 64 (2001), 107–122.
146. Yatomia, Y., Ozakia, Y., Ohmoria, T., Igarashi, Y., Sphingosine 1-phosphate: synthesis and release. Prostaglandins Other Lipid Mediat. 64 (2001), 107–122.
147. Young, M.M., Kester, M., Wang, H.G., Sphingolipids: regulators of crosstalk between apoptosis and autophagy. J. Lipid Res. 54 (2013), 5–19.
148. Zhang, J., Honbo, N., Goetzl, E.J., Chatterjee, K., Karliner, J.S., Gray, M.O., Signals from type 1 sphingosine 1-phosphate receptors enhance adult mouse cardiac myocyte survival during hypoxia. Am. J. Physiol. 293 (2007), H3150–3158.
149. Zhang, X., Tang, N., Hadden, T.J., Rishi, A.K., Akt, FoxO and regulation of apoptosis. Biochim. Biophys. Acta 1813 (2011), 1978–1986.